Insiders NovoCure Limited

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-05-15 pm EDT			5-day change	1st Jan Change
17.59 ^USD	+2.87%		+0.86%	-40.97%

Apr. 24	NovoCure's Q1 Loss Narrows, Revenue Rises	MT
Apr. 24	NovoCure Limited, Q1 2025 Earnings Call, Apr 24, 2025

Novocure Insider Sold Shares Worth $296,257, According to a Recent SEC Filing	Mar. 03	MT
Novocure FDA Approves Novocure?S Innovative HFE Transducer Arrays for Use with Optune Gio® for Glioblastoma	Nov. 21	CI
NovoCure Names New Chief Financial Officer	24-10-30	MT
NovoCure Limited Appoints Christoph Brackmann as Senior Financial Advisor	24-10-30	CI
NovoCure Limited Announces CFO Appointment	24-10-30	CI
NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor	24-09-03	MT
Novocure Announces CEO Changes, Effective January 1, 2025	24-09-03	CI
Novocure Announces Management Changes	24-09-03	CI
Novocure Names Nicolas Leupin as Chief Medical Officer	24-01-04	MT
NovoCure Limited Announces Executive Changes	24-01-04	CI
Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer	24-01-04	CI
Kristin Stafford Joins Novocure Board of Directors	23-03-29	CI
Insider Sell: Novocure	23-03-07	MT
Insider Sell: Novocure	23-03-07	MT
Insider Sell: Novocure	23-03-07	MT
Insider Sell: Novocure	23-03-07	MT
Insider Sell: Novocure	23-03-06	MT
Insider Sell: Novocure	23-03-03	MT
Insider Sell: Novocure	23-03-02	MT
Novocure Appoints Allyson J. Ocean to Board of Directors	23-02-23	CI
Novocure Announces Executive Changes	23-01-19	CI
Insider Sell: NovoCure	23-01-10	MT
Insider Sell: NovoCure	23-01-10	MT
Insider Sell: Novocure	22-10-17	MT

No results for this search